Senate Republicans blocked the $35 cap on out-of-pocket shelling out for insulin for patients signed up for private insurance.
Why it matters: The drug costs eight times more in the U.S. than 32 other high-income nations, according to a 2020 study commissioned by medical and Human Services Department.
What we’re watching: The change to the climate, tax and healthcare package came through the amendment process which allows any senator to force a vote on proposed tweaks to the measure.
- Seven Republicans voted with Democrats to help keep the insulin cap in the bill, but that has been insufficient to overcome the 60-vote threshold.
- The Republicans argued that the provision violated the guidelines of reconciliation following the Senate parliamentarian ruled that it’s not primarily linked to the federal budget.
Between your lines: Despite the fact that the $35 cap for the private insurers has been stripped from the package, Democrats are hoping to preserve the $35 insulin cap for patients on Medicare
- One atlanta divorce attorneys three Medicare beneficiaries has diabetes, and over 3.3 million Medicare beneficiaries use a number of of the normal types of insulin, based on the Department of Health insurance and Human Services.
The picture as a whole: Capping out-of-pocket insulin costs a narrow sliver of President Biden’s stalled Build Back Better package is a priority for Democrats, particularly before this year’s midterms.
- It is also captured the eye of several Republicans, resulting in some bipartisan efforts to craft legislation.